PYRAZOLO[3,4-a]ACRIDINES
2215
1047623, 1009511, 1046857, 1019265, and 1046856 respectively. Copies of the data can
be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge,
REFERENCES
1. (a)Albert, A.; The Acridines, 2nd ed.; Edward Arnold: London, 1996; (b) Groundwater, P.
W.; Munawar, M. A. in Advances in Heterocyclic Chemistry; A. R. Katritzky (Ed.);
Academic Press: New York, 1998; vol. 70, pp. 89–161.
2. Michael, J. P. Nat. Prod. Rep. 2007, 24, 223.
3. Wansi, J.D.; Wandji, J.; Mbaze Meva, L.; Kamdem Waffo, A. F.; Ranjit, R.; Khan, S. N.;
Asma, A.; Iqbal, C. M.; Lallemand, M.-C.; Tillequin, F.; Tanee, Z. F. Chem. Pharm. Bull.
2006, 54, 292.
4. Nguyen, H. T.; Lallemand, M.-C.; Boutefnouchet, S.; Michel, S.; Tillequin, F. J. Nat.
Prod. 2009, 72, 527.
5. Tarasiuk, J.; Majewska, E.; Seksek, O.; Rogacka, D.; Antonini, I.; Garnier-Suillerot, A.;
Borowski, E. Biochem. Pharmacol. 2004, 68, 1815.
6. (a) Behr, L. C.; Fusco, R.; Jarboe, C. H. In Pyrazoles, Pyrazolines, Pyrazolidines,
Indazoles and Condensed Rings; R. H. Wiley (Ed.); Interscience: New York, 1967; (b)
Liu, X. H.; Cui, P.; Song, B. A.; Bhadury, P. S.; Zhu, H. L.; Wang, S. F. Bioorg. Med.
Chem. 2008, 16, 4075; (c) Erhan, P.; Mutlu, A.; Tayfun, U.; Dilek, E. Eur. J. Med. Chem.
2001, 36, 539; (d) Kees, K. L.; Fitzgerald, J. J.; Steiner Jr., K. E.; Mattes, J. F.; Mihan, B.;
Tosi, T.; Mondoro, D.; McCaleb, M. L. J. Med. Chem. 1996, 39, 3920.
7. (a) Barros, F. W. A.; Silva, T. G.; Pitta, M. G.; Bezerra, D. P.; Costa-Lotufo, L. V.;
de Moraes, M. O.; Pessoa, C.; de Moura, M. A. F. B.; de Abreu, F. C.; de Lima, M.
A.; Galdino, S. L.; Pitta, I. R.; Goulart, M. O. F. Bioorg. Med. Chem. 2012, 20, 3533;
(b) Lang, X.; Lulu, L.; Chen, Y.; Sun, Q.; Qin, W.; Liu, F.; Tan, C.; Liu, H.; Gao, C.;
Jiang, Y. Bioorg. Med. Chem. 2013, 21, 4170–4177; (c) Capps, D. B.; Dunbar, J.; Kesten,
S. R.; Shillis. J.; Werbel, L. M. J. Med. Chem. 1992, 35, 4770; (d) Antonini, I.; Polucci, P.;
Magnano, A.; Martelli, S.; J. Med. Chem. 2001, 44, 3329; (e) Kostakis, I. K.; Magiatis, P.;
Pouli, N.; Marakos, P.; Skaltsounis, A. L.; Pratsinis, H.; Léonce, S.; Pierre, A. J. Med.
Chem. 2002, 45, 2599.
8. (a) Sebolt, J. S.; Scavone, S. V.; Pinter, C. D.; Hamelehle, K. L.; Vonhoff, D. D.; Jackson,
R. C. Cancer Res. 1987, 47, 4299; (b) Adjei, A. A. Invest New Drugs 1999, 17, 43.
9. Shurske, G.M.; Tomer, J. D. J. Heterocycl. Chem. 1993, 30, 23.
10. Demeunynck, M.; Charmantray, F.; Martelli, A. Curr. Pharm. Design 2001, 7, 1703.
11. (a) Friedländer, P. Ber. Deutsch. Chem. Ges. 1882, 15, 2572; (b) Eldelfield, R. C. In The
Chemistry of Heterocyclic Compounds; R. C. Eldelfield (Ed.); Wiley: New York, 1952;
Vol. 4, p. 45; (c) Jones, G. In The Chemistry of Heterocyclic Compounds: Quinolines; G.
Jones (Ed.); Wiley: New York, 1977; Part 1, p. 181; (d) Pflum, D. A. In Name Reactions
in Heterocyclic Chemistry; J. J. Li and E. J. Corey (Eds.); Wiley & Sons: Hoboken, NJ,
2005, pp. 411–415; (e) Marco-Contelles, J.; Pérez-Mayoral, E.; Samadi, A.; Carmo
Carreiras, M.; Soriano, E. Chem. Rev. 2009, 109(6), 2652; (f) Shiri, M.; Zolfigol, M. A.;
Kruger, H. G.; Tanbakouchain, Z. Adv. Heterocycl. Chem. 2001, 102, 139; (g) Madapa,
S.; Tusi, Z.; Batra, S. Curr. Org. Chem. 2008, 12, 1116; (h) Palimkar, S. S.; Siddiqui, S. A.;
Daniel, T.; Lahoti, R. J.; Srinivasan, K. V. J. Org. Chem. 2003, 68, 9371.
12. Hasaninejad, A.; Abdolkarim, Z.; Shekouhy, M.; Ameri-Rad, J. Green Chem. 2011, 13, 958.
13. Kumar, S. G.; Zeller, M.; Gonnade, R. G.; Rajendra Prasad, K. J. Tetrahedron Lett. 2014,
55 (30), 4240.
14. Eaton, E. P.; Glenn, R. C.; Lee, J. T. J. Org. Chem. 1973, 38, 4071.